# Nephrotoxicity of Iopamidol Versus Iodixanol in High-Risk Patients

> **NCT01402219** · PHASE4 · TERMINATED · sponsor: **Guangdong Provincial People's Hospital** · enrollment: 204 (actual)

## Conditions studied

- Chronic Renal Disease

## Interventions

- **DRUG:** Iopamidol injection 76%
- **DRUG:** iodixanol

## Key facts

- **NCT ID:** NCT01402219
- **Lead sponsor:** Guangdong Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-11
- **Primary completion:** 2013-02
- **Final completion:** 2013-05
- **Target enrollment:** 204 (ACTUAL)
- **Why stopped:** There were few eligible subjects from other centers.
- **Last updated:** 2013-08-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01402219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01402219, "Nephrotoxicity of Iopamidol Versus Iodixanol in High-Risk Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01402219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*